Abiopharma

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

McEwen Inc. Announces Voting Results of the 2026 Annual Meeting of Shareholders

TEN Holdings, Inc. Announces Pricing of $7.5 Million Offering

Rogers Sugar annonce la prolongation de la convention collective à sa raffinerie de Taber

Rogers Sugar Announces Extention of Collective Agreement at Taber Refinery

Aben Gold Receives Second Payment of Option Agreement

Brookfield Real Assets Income Fund Inc. Declares Q3 2026 Distribution Schedule

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

UTHR: Notification